Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy

BBA Clinical

Volumn 3, Issue , 2015, Pages 168-174

  Nagaya, Tadanobu ^a   Tanaka, Naoki ^a,b   Kimura, Takefumi ^a   Kitabatake, Hiroyuki ^a   Fujimori, Naoyuki ^a   Komatsu, Michiharu ^a   Horiuchi, Akira ^c   Yamaura, Takahiro ^d   Umemura, Takeji ^a   Sano, Kenji ^e   Gonzalez, Frank J ^f   Aoyama, Toshifumi ^b   Tanaka, Eiji ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Showa Inan General Hospital   (Japan)

^d Iida Municipal Hospital   (Japan)

^e SHINSHU UNIVERSITY HOSPITAL   (Japan)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Fatty acid; MyD88; NASH; Pancreaticoduodenectomy; VLDL

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALANINE AMINOTRANSFERASE; ALBUMIN; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; CELL NUCLEUS RECEPTOR; CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; FATTY ACID BINDING PROTEIN 4; GAMMA GLUTAMYLTRANSFERASE; LIVER X RECEPTOR ALPHA; MANGANESE SUPEROXIDE DISMUTASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FIBROSIS; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; LIPOGENESIS; LIVER BALLOONING; LIVER BIOPSY; LIVER CELL; LIVER INJURY; MACROVESICULAR STEATOSIS; MALNUTRITION; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PANCREATICODUODENECTOMY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEATOSIS; UPREGULATION;

EID: 84923652533     PISSN: 22146474     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbacli.2015.02.001     Document Type: Article

References (33)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 2011, 34:274-285.
2. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insight. Science 2011, 332:1519-1523.
3. Söderberg C., Stål P., Askling J., Glaumann H., Lindberg G., Marmur J., Hultcrantz R. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
4. Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010, 52:1836-1846.
5. Neuschwander-Tetri B.A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010, 52:774-788.
6. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1343-1351.
7. Tanaka N., Horiuchi A., Yokoyama T., Kaneko G., Horigome N., Yamaura T., Nagaya T., Komatsu M., Sano K., Miyagawa S., Aoyama T., Tanaka E. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J. Gastroenterol. 2011, 46:758-768.
8. Nakagawa N., Murakami Y., Uemura K., Sudo T., Hashimoto Y., Kondo N., Sasaki H., Okano K., Sueda T. Nonalcoholic fatty liver disease after pancreatoduodenectomy is closely associated with postoperative pancreatic exocrine insufficiency. J. Surg. Oncol. 2014, 110:720-726.
9. Nagai M., Sho M., Satoi S., Toyokawa H., Akahori T., Yanagimoto H., Yamamoto T., Hirooka S., Yamaki S., Kinoshita S., Nishiwada S., Ikeda N., Kwon A.H., Nakajima Y. Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. J. Hepatobiliary Pancreat. Sci. 2014, 21:186-192.
10. Nagaya T., Tanaka N., Suzuki T., Sano K., Horiuchi A., Komatsu M., Nakajima T., Nishizawa T., Joshita S., Umemura T., Ichijo T., Matsumoto A., Yoshizawa K., Nakayama J., Tanaka E., Aoyama T. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J. Hepatol. 2010, 53:724-731.
11. Komatsu M., Kimura T., Yazaki M., Tanaka N., Yang Y., Nakajima T., Horiuchi A., Fang Z.Z., Joshita S., Matsumoto A., Umemura T., Tanaka E., Gonzalez F.J., Ikeda S.I., Aoyama T. Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα. Biochem. Biophys. Acta. 2015, 1852:473-481.
12. Tanaka N., Nagaya T., Komatsu M., Horiuchi A., Tsuruta G., Shirakawa H., Umemura T., Ichijo T., Matsumoto A., Yoshizawa K., Aoyama T., Kiyosawa K., Tanaka E. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase. Liver Int. 2008, 28:1104-1111.
13. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
14. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 1998, 273:5678-5684.
15. Tanaka N., Moriya K., Kiyosawa K., Koike K., Gonzalez F.J., Aoyama T. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J. Clin. Invest. 2008, 118:683-694.
16. Yu S., Matsusue K., Kashireddy P., Cao W.Q., Yeldandi V., Yeldandi A.V., Rao M.S., Gonzalez F.J., Reddy J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 2003, 278:498-505.
17. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., Brewer B., Reitman M.L., Gonzalez F.J. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J. Clin. Invest. 2003, 111:737-747.
18. Kesar V., Odin J.A. Toll-like receptors and liver disease. Liver Int. 2014, 34:184-196.
19. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011, 14:593-605.
20. Greco D., Kotronen A., Westerbacka J., Puig O., Arkkila P., Kiviluoto T., Laitinen S., Kolak M., Fisher R.M., Hamsten A., Auvinen P., Yki-Järvinen H. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G1281-G1287.
21. Westerbacka J., Kolak M., Kiviluoto T., Arkkila P., Sirén J., Hamsten A., Fisher R.M., Yki-Järvinen H. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007, 56:2759-2765.
22. Zhu L., Baker S.S., Liu W., Tao M.H., Patel R., Nowak N.J., Baker R.D. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism 2011, 60:1001-1011.
23. Nakamura M.T., Yudell B.E., Loor J.J. Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res. 2014, 53:124-144.
24. Rinella M.E., Elias M.S., Smolak R.R., Fu T., Borensztajn J., Green R.M. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 2008, 49:1068-1076.
25. Pickens M.K., Yan J.S., Ng R.K., Ogata H., Grenert J.P., Beysen C., Turner S.M., Maher J.J. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. J. Lipid Res. 2009, 50:2072-2082.
26. Macfarlane D.P., Zou X., Andrew R., Morton N.M., Livingstone D.E., Aucott R.L., Nyirenda M.J., Iredale J.P., Walker B.R. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Am. J. Physiol. Endocrinol. Metab. 2011, 300:E402-E409.
27. Tanaka N., Takahashi S., Fang Z.Z., Matsubara T., Krausz K.W., Qu A., Gonzalez F.J. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. Biochim. Biophys. Acta 2014, 1841:1596-1607.
28. Goldberg R.F., Austen W.G., Zhang X., Munene G., Mostafa G., Biswas S., McCormack M., Eberlin K.R., Nguyen J.T., Tatlidede H.S., Warren H.S., Narisawa S., Millán J.L., Hodin R.A. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3551-3556.
29. Zhou Q.Q., Yang D.Z., Luo Y.J., Li S.Z., Liu F.Y., Wang G.S. Over-starvation aggravates intestinal injury and promotes bacterial and endotoxin translocation under high-altitude hypoxic environment. World J. Gastroenterol. 2011, 28:1584-1593.
30. Ren Z.G., Liu H., Jiang J.W., Jiang L., Chen H., Xie H.Y., Zhou L., Zheng S.S. Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation. Hepatobiliary Pancreat. Dis. Int. 2011, 10:489-496.
31. Serviddio G., Bellanti F., Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2013, 65:952-968.
32. Sung B., Park S., Yu B.P., Chung H.Y. Modulation of PPAR in aging, inflammation, and calorie restriction. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:997-1006.
33. Ye P., Zhang X.J., Wang Z.J., Zhang C. Effect of aging on the expression of peroxisome proliferator-activated receptor gamma and the possible relation to insulin resistance. Gerontology 2006, 52:69-75.